Effectiveness and safety of sorafenib 400 mg vs. 800 mg initial dose on survival in patients with advanced and intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis

Saved in:
Bibliographic Details
Published inAnnals of hepato-biliary-pancreatic surgery Vol. 26; no. Suppl 1; p. 314
Main Authors Roland HELMIZAR, Juferdy KURNIAWAN
Format Journal Article
LanguageEnglish
Published 한국간담췌외과학회 30.04.2022
Online AccessGet full text

Cover

More Information
ISSN:2508-5778
2508-5859
DOI:10.14701/ahbps.2022S1.EP-32